Case Study By Catalent Expert To Be Presented At PDA




Complex Biopharmaceuticals Tech Transfer Challenges - A Case Study by Catalent Expert to be Presented at PDA Annual Meeting

Somerset, NJ, April 3, 2012 – Edwin Hoppenbrouwers, Director of New Product Introduction, Sterile Technologies, Catalent Pharma Solutions, will be presenting “Challenging Technical Transfer of a Biopharmaceutical – the Product X Case Study” at the 2012 PDA Annual Meeting in Phoenix, AZ on Monday, April 16, 2012, between 10:30 a.m. and 11:15 a.m.
Mr. Hoppenbrouwers’ presentation will focus on Catalent’s expertise in providing solutions for tech transfer projects when working with complex products and will address the following common challenges:

  • temperature instability,
  • formulation development and manufacturing issues, and
  • visual inspection, packaging, and frozen chain supply distribution for complex biopharmaceutical products.

Throughout this case study, Mr. Hoppenbrouwers will demonstrate the ability to identify novel approaches and manufacturing best practices which allows Catalent to provide reliable solutions for the most challenging tech transfer projects.

Mr. Hoppenbrouwers is Catalent’s Director of New Product Development for Sterile Technologies. He has a Masters Degree in Chemical Engineering and is licensed in pharmaceutical engineering. He has extensive experience in pharmaceutical research and development and expertise with sterile facility design, project management, and technical sales.

To arrange a follow-up interview with Edwin Hoppenbrouwers, please contact Patricia McGee at: media@catalent.com .

For more information or to register for the conference, visit: www.pda.org

To learn more about our sterile technologies click here , to learn more about Catalent visit, www.catalent.com/sterile

About Catalent

From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 9,400 people at 29 facilities worldwide and in fiscal year 2011 generated more than $1.6 billion in annual revenue. Catalent is headquartered in Somerset, NJ.

more products. better treatments. reliably supplied.™